Dec 5, 2024

Featuring perspectives from Dr Priyanka Sharma and Dr Sara M Tolaney, including the following topics:

• Introduction: Metastatic Triple-Negative Breast Cancer (mTNBC) — The Patient Perspective (0:00)
• Selection and Sequencing of Antibody-Drug Conjugates (5:09)
• Dosing and Tolerability of Sacituzumab Govitecan; Use of...

Nov 26, 2024

Featuring an interview with Dr Seth Wander, including the following topics:

• ASCO Guidelines Rapid Recommendations Update for Testing for ESR1 Mutations (0:00)
• Real-world elacestrant use patterns and genomic biomarkers (4:43)
• Circulating tumor DNA (ctDNA) analyses with imlunestrant in the EMBER Phase I study (8:50)

Nov 19, 2024

Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities — Hope S Rugo, MD

CME information and select publications

Nov 19, 2024

Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

• Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
• First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
• Treatment Options for Recurrent mBC...

Nov 16, 2024

Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander, including the following topics:

• Introduction (0:00)
• Hormone Receptor-Positive Breast Cancer —...